TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28161306

Group type: EXPERIMENTAL
Intervention: Exercise group (n=150): cycling exercise 3 times per week, at least 30 min/session, initiated within 3 days of randomization until 37 weeks of gestation.
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Exercise group (n=150)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (n=150)
Number of subjects: 300
Study: 26665289

Group type: EXPERIMENTAL
Intervention: Arm & Hammer Truly Radiant Rejuvenating toothpaste
Number of subjects: 54

Group type: COMPARATOR
Intervention: Colgate Cavity Protection toothpaste (negative control)
Number of subjects: 54
Study: 23995858

Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 1970

Group type: COMPARATOR
Intervention: CTD (cyclophosphamide-thalidomide-dexamethasone)
Number of subjects: 1970

Group type: EXPERIMENTAL
Intervention: CTDa (attenuated CTD)
Number of subjects: 1970

Group type: EXPERIMENTAL
Intervention: Thalidomide maintenance
Number of subjects: 1970
Study: 21104485

Group type: EXPERIMENTAL
Intervention: Hypnotherapy
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CLEAR NPT
Number of subjects: 30
Study: 19452709

Group type: EXPERIMENTAL
Intervention: Ibudilast
Number of subjects: 69

Group type: COMPARATOR
Intervention: loratadine
Number of subjects: 69
Study: 17908564

Group type: EXPERIMENTAL
Intervention: Hippotherapy
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sitting astride a Bobath roll
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sitting on a stool with rocking seat
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control condition (spasticity measurement without intervention)
Number of subjects: 12
Study: 15215018

Group type: COMPARATOR
Intervention: Laparoscopic hysterectomy (LH)
Number of subjects: 1380

Group type: COMPARATOR
Intervention: Abdominal laparoscopic hysterectomy (ALH)
Number of subjects: 1380

Group type: COMPARATOR
Intervention: Vaginal laparoscopic hysterectomy (VLH)
Number of subjects: 1380

Group type: EXPERIMENTAL
Intervention: Standard abdominal hysterectomy (AH)
Number of subjects: 1380
Study: 11234182

Group type: EXPERIMENTAL
Intervention: Weekly home fructosamine monitoring in addition to daily glucose monitoring
Number of subjects: 140

Group type: COMPARATOR
Intervention: Daily glucose monitoring only (Control)
Number of subjects: 140
Study: 15034317

Group type: EXPERIMENTAL
Intervention: UDCA (600 mg/day for 12 months)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (B)
Number of subjects: 74
Study: 8359567

Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: COMPARATOR
Intervention: Historical series
Number of subjects: 27
Study: 3706881

Group type: EXPERIMENTAL
Intervention: Inhaled isoproterenol
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intravenously administered aminophylline (17.0 to 22.4 mg/L)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Intravenously administered aminophylline plus inhaled isoproterenol
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intravenously administered placebo
Number of subjects: 8
Study: 31939515

Group type: EXPERIMENTAL
Intervention: Telephone contact
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: SMS or WhatsApp
Number of subjects: 78

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 78
Study: 29868973

Group type: EXPERIMENTAL
Intervention: Liberal oxygenation group (SpO2 targets > 94%)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Conservative oxygenation group (SpO2 = 88-92%)
Number of subjects: 159
Study: 27513475

Group type: EXPERIMENTAL
Intervention: 6-week online gratitude intervention
Number of subjects: 67

Group type: COMPARATOR
Intervention: 6-week online control condition
Number of subjects: 67
Study: 25088739

Group type: EXPERIMENTAL
Intervention: EndoAnchors implanted in 242 patients (75.9%) during initial EVAR procedure
Number of subjects: 319

Group type: COMPARATOR
Intervention: EndoAnchors implanted in 77 patients with existing endograft and proximal aortic neck complications
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: EndoAnchors used prophylactically in patients with hostile aortic neck anatomy
Number of subjects: 319
Study: 22362838

Group type: EXPERIMENTAL
Intervention: Telehealth intervention group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 21036822

Group type: EXPERIMENTAL
Intervention: Full screening intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screened ceilings intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: No screening (control)
Number of subjects: 0
Study: 18395345

Group type: EXPERIMENTAL
Intervention: Duloxetine 120 mg/day
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg/day
Number of subjects: 520

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 520
Study: 15918560

Group type: EXPERIMENTAL
Intervention: Chemotherapy and/or radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical resection
Number of subjects: 0
Study: 11909787

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion
Number of subjects: 600

Group type: COMPARATOR
Intervention: Optimised insulin injections
Number of subjects: 600
Study: 12377361

Group type: EXPERIMENTAL
Intervention: Four-session guided self-change treatment
Number of subjects: 93

Group type: COMPARATOR
Intervention: One-session advice treatment
Number of subjects: 93
Study: 9846012

Group type: EXPERIMENTAL
Intervention: Response-oriented individualized induction therapy with six drugs (doxorubicin, mitoxantrone, vincristine, prednisolone, cyclophosphamide, L-asparaginase)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Allogeneic bone marrow transplantation (allo-BMT)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Induction therapy with leukocytes < 30,000/microliter and blasts < 10% on day 15
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Overall results compared to former ALL87 protocol
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Patients with good prognostic factors (leukocyte < 30,000/microliter and age < 30 years old)
Number of subjects: 180
Study: 7854594

Group type: EXPERIMENTAL
Intervention: 0.5 ml/kg ethanol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2509264

Group type: EXPERIMENTAL
Intervention: Rectal diazepam
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Sodium valproate
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Phenobarbitone
Number of subjects: 186

Group type: COMPARATOR
Intervention: Prophylactic treatment (sodium valproate or phenobarbitone)
Number of subjects: 186
Study: 807007

Group type: EXPERIMENTAL
Intervention: Parenteral 1.75 per cent L‐essential amino acids in 47 per cent dextrose (Group I)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 47 per cent dextrose (Group II)
Number of subjects: 20
Study: 31574511

Group type: EXPERIMENTAL
Intervention: 6% TAAC poloxamer 407 hydrogel
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 30% TAAC hydrogel
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study: 28318451

Group type: EXPERIMENTAL
Intervention: Bacterial lysate administered 10 days per month for 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 25231114

Group type: EXPERIMENTAL
Intervention: Point-of-care nerve conduction device (POCD; NC-stat®|DPNCheck™)
Number of subjects: 162

Group type: COMPARATOR
Intervention: LDIFLARE technique
Number of subjects: 162
Study: 23167925

Group type: EXPERIMENTAL
Intervention: Ethosuximide
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Valproic acid
Number of subjects: 446

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 446

Group type: COMPARATOR
Intervention: Ethosuximide and Valproic acid
Number of subjects: 446
Study: 22082582

Group type: EXPERIMENTAL
Intervention: Coronary stent trials (1995-1997)
Number of subjects: 10253

Group type: EXPERIMENTAL
Intervention: Coronary stent trials (1998-2002)
Number of subjects: 10253

Group type: EXPERIMENTAL
Intervention: Coronary stent trials (2003-2006)
Number of subjects: 10253
Study: 19420182

Group type: EXPERIMENTAL
Intervention: Morning-dosed atomoxetine
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Evening-dosed atomoxetine
Number of subjects: 288

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 288
Study: 16485883

Group type: EXPERIMENTAL
Intervention: 3% diclofenac sodium gel used for 90 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: 5% 5-fluorouracil cream used for 28 days
Number of subjects: 30
Study: 15344544

Group type: EXPERIMENTAL
Intervention: Endoscopic treatment (methods include Endoluminal Gastroplication, Full Thickness Plicator, Stretta, Enteryx, Gatekeeper)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medication and laparoscopic antireflux surgery
Number of subjects: 0
Study: 10645920

Group type: EXPERIMENTAL
Intervention: High antibody levels to herpes simplex type I (HSV‐1)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: High antibody levels to Chlamydia pneumoniae (Cpn)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: High C-reactive protein (CRP) levels
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Joint effect of high antibody levels to HSV‐1 and Cpn
Number of subjects: 241

Group type: COMPARATOR
Intervention: Low antibody levels and low CRP
Number of subjects: 241
Study: 9080161

Group type: EXPERIMENTAL
Intervention: Bubble oxygenator (Harvey 1700)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Membrane oxygenator (Cobe CML)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Both oxygenators
Number of subjects: 61
Study: 8436156

Group type: EXPERIMENTAL
Intervention: Amitriptyline (50 mg and 100 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Amoxapine (100 mg and 200 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30699060

Group type: EXPERIMENTAL
Intervention: Pazufloxacin 0.6% ophthalmic solution (BID, n = 90)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Pazufloxacin 0.6% ophthalmic solution (TID, n = 76)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Pazufloxacin 0.6% ophthalmic solution (QID, n = 68)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Moxifloxacin 0.5% TID (n = 82)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Gatifloxacin 0.3% TID (n = 72)
Number of subjects: 300
Study: 28857945

Group type: EXPERIMENTAL
Intervention: Adapted motivational interviewing (MI)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Usual care (routine explanation by an ophthalmologist and an educational pamphlet)
Number of subjects: 276
Study: 25082710

Group type: EXPERIMENTAL
Intervention: Simulation scenarios on cardiac arrhythmia
Number of subjects: 91

Group type: COMPARATOR
Intervention: Traditional lecture on cardiac arrhythmia
Number of subjects: 91
Study: 23391599

Group type: EXPERIMENTAL
Intervention: Prophylactic paracetamol (PP) group
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Non-prophylactic paracetamol (NPP) group
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control group (unprimed children)
Number of subjects: 220
Study: 22023417

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided DPNB
Number of subjects: 66

Group type: COMPARATOR
Intervention: Anatomical landmark technique DPNB
Number of subjects: 66
Study: 19860305

Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Opioids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 17477886

Group type: EXPERIMENTAL
Intervention: Agomelatine 25 mg/d for 42 days
Number of subjects: 15
Study: 14977803

Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg p.o. preoperatively followed by placebo
Number of subjects: 50

Group type: COMPARATOR
Intervention: Diclofenac 50 mg p.o. (three doses)
Number of subjects: 50
Study: 11824249

Group type: EXPERIMENTAL
Intervention: Segmental resection and endoscopic surveillance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extended prophylactic surgery
Number of subjects: 0
Study: 9786475

Group type: EXPERIMENTAL
Intervention: Single oral doses of DW-116 (100, 200, 300, and 800 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple oral doses of DW-116 (300 mg for 7 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple oral doses of DW-116 (400 mg for 7 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single and multiple dosing of DW-116
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DW-116 taken before a high-fat breakfast
Number of subjects: 0
Study: 8147929

Group type: EXPERIMENTAL
Intervention: Intraarticular injections of hyaluronan (2.5 ml, weekly for 5 weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (vehicle, saline)
Number of subjects: 52
Study: 3256414

Group type: EXPERIMENTAL
Intervention: Eating a 3100 kJ cold meal
Number of subjects: 8

Group type: COMPARATOR
Intervention: Auscultation method (Korotkoff I, IV, and V)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Automated device with a microphone over the brachial artery
Number of subjects: 8

Group type: COMPARATOR
Intervention: Graphical analysis of microphone signals
Number of subjects: 8
Study: 31664765

Group type: EXPERIMENTAL
Intervention: Cariprazine 3 mg/day
Number of subjects: 2558

Group type: EXPERIMENTAL
Intervention: Cariprazine 4.5 mg/day
Number of subjects: 2558

Group type: EXPERIMENTAL
Intervention: Cariprazine (dose range 1.5-6 mg/day for schizophrenia and 3-6 mg/day for bipolar mania)
Number of subjects: 2558

Group type: EXPERIMENTAL
Intervention: Cariprazine (dose increase)
Number of subjects: 2558

Group type: EXPERIMENTAL
Intervention: Total cariprazine exposures
Number of subjects: 2558

Group type: EXPERIMENTAL
Intervention: Time-weighted cariprazine exposures
Number of subjects: 2558
Study: 29890298

Group type: EXPERIMENTAL
Intervention: Interventions targeting sleep and pain catastrophizing
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Helplessness component of catastrophizing and insomnia severity
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Interventions targeting pain-related helplessness
Number of subjects: 156
Study: 28395915

Group type: EXPERIMENTAL
Intervention: Bolus
Number of subjects: 106

Group type: COMPARATOR
Intervention: No Bolus
Number of subjects: 106
Study: 25751176

Group type: EXPERIMENTAL
Intervention: Preventive Basic Care Management (PBCM) program
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 99
Study: 23009037

Group type: EXPERIMENTAL
Intervention: Single vision lenses with full correction
Number of subjects: 200

Group type: COMPARATOR
Intervention: Single vision lenses with undercorrection of +0.50 D
Number of subjects: 200
Study: 20497513

Group type: EXPERIMENTAL
Intervention: EBM-matched PLTs
Number of subjects: 9

Group type: COMPARATOR
Intervention: CREG-matched PLTs
Number of subjects: 9

Group type: COMPARATOR
Intervention: A/BU-matched PLTs
Number of subjects: 9
Study: 18617483

Group type: EXPERIMENTAL
Intervention: Baseline NT-pro-BNP ≥ 9252 pg/mL (fourth quartile)
Number of subjects: 1255

Group type: EXPERIMENTAL
Intervention: Doubling of NT-pro-BNP
Number of subjects: 1255

Group type: EXPERIMENTAL
Intervention: Change in NT-pro-BNP
Number of subjects: 1255

Group type: EXPERIMENTAL
Intervention: Baseline or change in NT-pro-BNP
Number of subjects: 1255
Study: 16416313

Group type: EXPERIMENTAL
Intervention: S447X allele carriers
Number of subjects: 146
Study: 14560895

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 11973949

Group type: EXPERIMENTAL
Intervention: Reflexology
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo reflexology
Number of subjects: 12
Study: 9036439

Group type: EXPERIMENTAL
Intervention: CT imaging
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MRI imaging
Number of subjects: 10
Study: 1728070

Group type: EXPERIMENTAL
Intervention: Glucose IVN (36 kcal.kg-1.day-1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lipid IVN (37 kcal.kg-1.day-1)
Number of subjects: 20
Study: 6420831

Group type: EXPERIMENTAL
Intervention: Thioridazine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mesoridazine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thioridazine plus metabolites
Number of subjects: 0
Study: 30806695

Group type: EXPERIMENTAL
Intervention: Patient-Centered Care Transitions in HF transitional care model (n = 1104 patients)
Number of subjects: 2494
Study: 29069041

Group type: COMPARATOR
Intervention: Fiber-free nutrition formula (FF group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Fiber-enriched nutrition formula (FE group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Fiber- and probiotic-enriched nutrition formula (FEP group)
Number of subjects: 120
Study: 26553705

Group type: EXPERIMENTAL
Intervention: Mock news article about NIPS
Number of subjects: 1789

Group type: COMPARATOR
Intervention: Mock news article about amniocentesis
Number of subjects: 1789

Group type: COMPARATOR
Intervention: No article
Number of subjects: 1789
Study: 25057845

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIT) on an aquatic treadmill
Number of subjects: 18
Study: 21923329

Group type: EXPERIMENTAL
Intervention: 1% lidocaine solution
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study: 20128335

Group type: EXPERIMENTAL
Intervention: Stimulating massage applied to thigh muscles for 10 min on the affected leg
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (no massage)
Number of subjects: 19
Study: 17218881

Group type: EXPERIMENTAL
Intervention: Massage from student therapists with 950 h of didactic training
Number of subjects: 895

Group type: COMPARATOR
Intervention: Massage from student therapists with 700 h of didactic training
Number of subjects: 895

Group type: COMPARATOR
Intervention: Massage from student therapists with 450 h of didactic training
Number of subjects: 895
Study: 15114391

Group type: EXPERIMENTAL
Intervention: Biventricular pacing with one lead via coronary sinus and one lead endocardially at the apex of the right ventricle
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biventricular pacing combined with cardioverter defibrillator units
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Biventricular pacing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Echocardiographic methods for patient selection
Number of subjects: 0
Study: 11531681

Group type: EXPERIMENTAL
Intervention: ondansetron 4 mg (2 mg.ml‐1 solution) diluted into a 5‐ml solution
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 50 mg lidocaine (5 ml 1% solution)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 5 ml of intravenous 0.9% sodium chloride solution (placebo)
Number of subjects: 60
Study: 9430812

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Maprotiline
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 8517715

Group type: EXPERIMENTAL
Intervention: Probenecid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Allopurinol riboside
Number of subjects: 0
Study: 3155379

Group type: EXPERIMENTAL
Intervention: Vaccinia melanoma oncolysate (VMO) at higher doses (1.5 and 2.0 mg) with immediate treatment schedule
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Vaccinia melanoma oncolysate (VMO) with delayed treatment schedule
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (pretreatment sera)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Anti-HLA antibody and circulating immune complexes
Number of subjects: 48
Study: 31774306

Group type: EXPERIMENTAL
Intervention: Intragastric quinine 600 mg (Q600)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Intragastric quinine 275 mg (Q275)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control
Number of subjects: 27
Study: 29353026

Group type: EXPERIMENTAL
Intervention: Lebrikizumab 125 mg every 4 weeks
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo every 4 weeks
Number of subjects: 209
Study: 27184735

Group type: EXPERIMENTAL
Intervention: Reiki with Music Group
Number of subjects: 37

Group type: COMPARATOR
Intervention: Music Only Group
Number of subjects: 37
Study: 25752109

Group type: EXPERIMENTAL
Intervention: Negative pressure drainage
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (no negative pressure drainage)
Number of subjects: 102
Study: 23435143

Group type: EXPERIMENTAL
Intervention: Dai-kenchu-to (DKT) 2.5 g administered orally three times a day from postoperative day (POD) 1
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 32
Study: 19812935

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate infusion (n = 6)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo infusion (n = 6)
Number of subjects: 12
Study: 18294318

Group type: EXPERIMENTAL
Intervention: Daylight-PDT (continuous activation of porphyrins)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional red LED light-PDT (37 J cm(‐2))
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional red LED light-PDT
Number of subjects: 29
Study: 15808240

Group type: EXPERIMENTAL
Intervention: Antioxidants and zinc supplementation
Number of subjects: 3294
Study: 12554899

Group type: EXPERIMENTAL
Intervention: Pigtail drainage combined with anti-TB drug treatment
Number of subjects: 61

Group type: COMPARATOR
Intervention: Only anti-TB drugs
Number of subjects: 61
Study: 11054390

Group type: EXPERIMENTAL
Intervention: Interferon-ribavirin combination therapy for 24 weeks
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Interferon-ribavirin combination therapy for 48 weeks
Number of subjects: 53

Group type: COMPARATOR
Intervention: Interferon monotherapy
Number of subjects: 53
Study: 8814494

Group type: EXPERIMENTAL
Intervention: Steam-PS dialyser
Number of subjects: 31

Group type: COMPARATOR
Intervention: ETO-PS dialyser
Number of subjects: 31

Group type: COMPARATOR
Intervention: Cuprophan dialyser
Number of subjects: 31
Study: 1323324

Group type: EXPERIMENTAL
Intervention: ACTH (1 mg i.m. in long-acting form)
Number of subjects: 64
Study: 6830408

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxazepam
Number of subjects: 0
Study: 31841498

Group type: EXPERIMENTAL
Intervention: 10 μg daily vitamin D supplementation
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: 30 μg daily vitamin D supplementation
Number of subjects: 761

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: Low 25(OH)D haplotypes
Number of subjects: 761

Group type: EXPERIMENTAL
Intervention: High 25(OH)D haplotypes
Number of subjects: 761